tiprankstipranks
Aoyuan Healthy Life Group Co. Ltd. (HK:3662)
:3662
Hong Kong Market
Want to see HK:3662 full AI Analyst Report?

Aoyuan Healthy Life Group Co. Ltd. (3662) AI Stock Analysis

1 Followers

Top Page

HK:3662

Aoyuan Healthy Life Group Co. Ltd.

(3662)

Select Model
Select Model
Select Model
Neutral 61 (OpenAI - 5.2)
Rating:61Neutral
Price Target:
HK$0.42
▼(-4.09% Downside)
Action:Reiterated
Date:06/23/26
The score is held back primarily by weakening financial performance—multi-year revenue decline, margin compression, and a sharp 2025 free cash flow drop—despite a de-risked balance sheet. Technicals are moderately supportive in the near term (positive MACD; price above short-term averages), and valuation is a key offset with a low P/E and high dividend yield.
Positive Factors
De-risked balance sheet
A markedly lower debt-to-equity (≈0.05 in 2025) materially reduces financial risk and interest burden, giving the company durable flexibility to withstand revenue softness, fund working capital or targeted investments, and maintain operations without leveraging heavily.
Negative Factors
Multi-year revenue decline
Four consecutive years of revenue decline signal structural weakness in demand or competitive position. Persistent top-line erosion reduces scale economies, limits margin recovery options, and constrains reinvestment capacity, pressuring long-term growth prospects.
Read all positive and negative factors
Positive Factors
Negative Factors
De-risked balance sheet
A markedly lower debt-to-equity (≈0.05 in 2025) materially reduces financial risk and interest burden, giving the company durable flexibility to withstand revenue softness, fund working capital or targeted investments, and maintain operations without leveraging heavily.
Read all positive factors

Aoyuan Healthy Life Group Co. Ltd. (3662) vs. iShares MSCI Hong Kong ETF (EWH)

Aoyuan Healthy Life Group Co. Ltd. Business Overview & Revenue Model

Company Description
Operating within the People's Republic of China, Aoyuan Healthy Life Group Company Limited, through its various subsidiaries, specializes in delivering comprehensive property management and commercial operations solutions. Its property management ...
How the Company Makes Money
The specific breakdown of Aoyuan Healthy Life Group Co., Ltd.’s revenue streams and partnerships is null....

Aoyuan Healthy Life Group Co. Ltd. Financial Statement Overview

Summary
Balance sheet strength (very low and improving leverage; debt-to-equity ~0.05 in 2025) is a clear positive, but it is outweighed by weakening operations and cash generation. Revenue has declined for four consecutive years (2022–2025) with margin compression (net margin ~10.1% to ~4.2% from 2023 to 2025), and 2025 free cash flow fell sharply (~58% YoY) after stronger 2023–2024.
Income Statement
44
Neutral
Balance Sheet
72
Positive
Cash Flow
36
Negative
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue1.22B1.36B1.56B1.63B1.94B
Gross Profit312.54M385.04M399.62M397.21M469.57M
EBITDA131.02M160.95M198.54M245.27M-108.96M
Net Income51.57M96.22M157.14M160.41M-190.94M
Balance Sheet
Total Assets2.23B2.36B2.28B2.22B2.29B
Cash, Cash Equivalents and Short-Term Investments1.01B1.05B984.50M857.81M1.21B
Total Debt65.29M81.69M114.94M158.29M412.59M
Total Liabilities997.36M1.11B1.13B1.23B1.50B
Stockholders Equity1.21B1.20B1.10B931.48M747.32M
Cash Flow
Free Cash Flow31.62M107.61M93.52M-108.95M-98.54M
Operating Cash Flow37.98M140.33M106.01M-105.68M-86.34M
Investing Cash Flow-1.37M-30.53M67.93M-50.65M31.09M
Financing Cash Flow-69.06M-51.28M-48.34M-272.10M-245.32M

Aoyuan Healthy Life Group Co. Ltd. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.44
Price Trends
50DMA
0.31
Positive
100DMA
0.34
Positive
200DMA
0.39
Positive
Market Momentum
MACD
0.02
Negative
RSI
81.44
Negative
STOCH
87.91
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:3662, the sentiment is Positive. The current price of 0.44 is above the 20-day moving average (MA) of 0.35, above the 50-day MA of 0.31, and above the 200-day MA of 0.39, indicating a bullish trend. The MACD of 0.02 indicates Negative momentum. The RSI at 81.44 is Negative, neither overbought nor oversold. The STOCH value of 87.91 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:3662.

Aoyuan Healthy Life Group Co. Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
68
Neutral
HK$171.98M1.5315.16%11.22%4.17%10.89%
65
Neutral
$2.17B12.193.79%4.94%3.15%1.96%
61
Neutral
HK$290.50M4.864.27%6.60%-9.97%-46.38%
55
Neutral
HK$238.63M1.453147.50%-4.36%1481.82%
55
Neutral
HK$330.45M-3.69-9.16%15.45%1.07%-1080.00%
46
Neutral
HK$136.95M-3.130.24%-7.38%-374.13%
39
Underperform
HK$128.50M-0.484.36%-5.08%-682.55%
* Real Estate Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:3662
Aoyuan Healthy Life Group Co. Ltd.
0.40
-0.17
-29.82%
HK:1153
Jiayuan Services Holdings Limited
0.36
-0.10
-21.11%
HK:1895
Xinyuan Property Management Service (Cayman) Ltd.
0.29
-0.19
-39.58%
HK:1971
Redsun Services Group Ltd
0.33
-0.07
-17.50%
HK:2107
First Service Holding Limited
0.27
>-0.01
-2.88%
HK:2215
Dexin Services Group Ltd.
0.14
-0.66
-82.50%

Aoyuan Healthy Life Group Co. Ltd. Corporate Events

Starjoy Wellness and Travel Wins Full Shareholder Backing at 2026 AGM
May 22, 2026
Starjoy Wellness and Travel Company Limited reported that all resolutions at its 22 May 2026 annual general meeting were approved by shareholders by way of poll. Investors adopted the 2025 audited financial statements, confirmed Zhonghui Anda CPA ...
Starjoy Wellness and Travel Sets 2026 AGM to Seek Shareholder Mandates on Capital and Governance
Apr 22, 2026
Starjoy Wellness and Travel Company Limited has called its annual general meeting for 22 May 2026 in Hong Kong to review the audited consolidated financial statements for the year ended 31 December 2025 and receive reports from directors and audit...
Starjoy Directors Complete Mandated Training After HKEX Disciplinary Action
Apr 14, 2026
Starjoy Wellness and Travel Company Limited has confirmed that five of its directors, previously subject to disciplinary action by the Hong Kong Stock Exchange for breaches of Listing Rules, have completed 26 hours of mandated training on regulato...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jun 23, 2026